Lupin has received approval from USFDA for its pregnancy prevention tablets. The company has received final approval for its Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets...
Lupin’s marketing authorization application (MAA) for biosimilar Etanercept has been accepted for review by Europe drug regulator, European Medicines Agency (EMA). MAA means an application submitted by...
The US health regulator has completed inspection of Lupin’s Nagpur facility, without making any observation. The company in a BSE filing, “announced successful completion of...
Lupin’s Pithampur unit 2 manufacturing facility located in Indore, has been cleared by Health Canada after a review. In a BSE filing it stated, “Following the...